-
Joint session to explore potential of in vivo gene therapy
Ex vivo gene therapy for malignancies and genetic diseases is time consuming, expensive, and physically taxing on patients. John DiPersio, MD, PhD, and Hans-Peter Kiem, MD, PhD, preview this joint session presented by ASTCT and ASGCT on the in vivo alternatives.
-
Session to preview non-malignant biorepository for study coordinators
Larisa Broglie, MD, MS, will give an overview of a study being developed as part of the Blood & Marrow Transplant Clinical Trials Network, which aims to build a biorepository of samples from patients with non-malignant diseases who will undergo hematopoietic cell transplantation and gene therapy for select diseases.
-
Panel to examine landscape of antiviral therapy in pediatric transplant
Caitlin Elgarten, MD, MSCE, previews the positive developments and ongoing challenges that will be addressed in this session on drug development for the treatment and prevention of viral infection in children after transplant.
-
Infectious Diseases Track expands to a full day
The agenda includes cutting-edge ID research in the field of chimeric antigen receptor T-cell (CAR T) therapy and allogeneic stem cell transplantation, as well as returning attendee favorites such as an interactive trivia game, a focus on the best ID abstracts, and information on updated guidelines, says Track Vice Chair Zainab Shahid, MBBS.
-
BMT CTN Track to address new grant cycle, coordinators’ mental health, and real-world experiences
Blood and Marrow Transplant Clinical Trials Network Clinical Program Manager Mykala Heuer, BSN, RN, outlines highlights in the agenda, including discussions on operations, empowering coordinators, and changes in study endpoints.
-
Administrative Director Track to detail emerging best practices amid swift evolution of field
Track Co-Chairs Mark Duckworth, BS, and Julie Porter, MS, preview an agenda full of panel discussions delving into the challenges facing transplant and cellular and gene therapy program administrators and the innovative solutions they have developed to overcome them.
-
IT and Informatics Track to focus on data strategies and success stories
Data standardization and interoperability, and the automation of data acquisition and transfer for research purposes will be recurring themes throughout the agenda, as explained by track planners including Erik Bergman, MBA, MS.
-
Chat with colleagues, catch up on industry developments, and help restore a waterway in the Exhibit Hall
Tandem Meetings Program Coordinator Ashley Wissinger describes the activities and amenities that await 2025 Tandem Meetings attendees in the Exhibit Hall.
-
Pediatric Track offers timely updates on complex conditions in children
A full day of programming is dedicated to the tailored treatments that are required to care for this uniquely vulnerable patient population, explains Michael Verneris, MD, in a preview of the Pediatric Track agenda.
-
Pharmacy Track highlights CAR-T therapy side effects, bridging chemotherapy, GVHD management
Track Chair Nicole Daukshus, PharmD, BCOP, outlines what attendees can expect from this programming, including presentations on immunotherapy, gene therapy, and transplant complications.